VPS24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.40998324127395E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.02939999968577E-07 |
Normal-vs-Stage2 |
4.34770000001805E-08 |
Normal-vs-Stage3 |
1.63324909152607E-12 |
Normal-vs-Stage4 |
<1E-12 |
Stage1-vs-Stage2 |
3.345700E-02 |
Stage1-vs-Stage3 |
1.9208799999948E-05 |
Stage1-vs-Stage4 |
7.79150000074225E-09 |
Stage2-vs-Stage3 |
2.972800E-01 |
Stage2-vs-Stage4 |
1.251890E-02 |
Stage3-vs-Stage4 |
9.938300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6636692024008E-12 |
Normal-vs-AfricanAmerican |
9.24940002366981E-09 |
Normal-vs-Asian |
2.504000E-01 |
Caucasian-vs-AfricanAmerican |
2.555400E-01 |
Caucasian-vs-Asian |
4.919200E-01 |
AfricanAmerican-vs-Asian |
2.907800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.88258347483861E-15 |
Normal-vs-Female |
1.09039999252047E-10 |
Male-vs-Female |
2.732400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.428300E-04 |
Normal-vs-Age(41-60Yrs) |
1.17550413847312E-11 |
Normal-vs-Age(61-80Yrs) |
1.66666680456728E-12 |
Normal-vs-Age(81-100Yrs) |
2.042800E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.076800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.841600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.133000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.773400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.283200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.661800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.826000E-01 |
Normal-vs-Grade 2 |
9.7367000018167E-08 |
Normal-vs-Grade 3 |
1.62503344114384E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
7.291500E-02 |
Grade 1-vs-Grade 3 |
1.721190E-03 |
Grade 1-vs-Grade 4 |
2.31509999999435E-05 |
Grade 2-vs-Grade 3 |
5.91859999999889E-05 |
Grade 2-vs-Grade 4 |
1.0865999988674E-08 |
Grade 3-vs-Grade 4 |
7.481700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.11900000000043E-05 |
Normal-vs-ccB subtype |
1.62581059726108E-12 |
ccA subtype-vs-ccB subtype |
1.66950000046739E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.39663844325833E-12 |
Normal-vs-N1 |
4.630600E-04 |
N0-vs-N1 |
1.000600E-01 |
|
|